SEC Form 4 · accession 0001387131-18-001156
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Cannon
Director
Period of report
Mar 16, 2018
Accepted (ET)
Mar 20, 2018 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | holding | — | — | — | 7,557,436 | I | see footnotes | |
| Common StockF3 | holding | — | — | — | 62,268 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2,F4 | $1.25 | Mar 16, 2018 | A | 40,000 | A | Mar 16, 2018 | — | Common Stock | 800,000 | 40,000 | I |
| WarrantF2 | $1.40 | Mar 16, 2018 | A | 350,000 | A | Sep 16, 2018 | Mar 16, 2028 | Common Stock | 350,000 | 350,000 | I |
Explanation of responses
- F1These securities were inadvertently omitted from Dr. Cannon's prior Section 16 reports.
- F2Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
- F350,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F4The preferred stock is perpetual and therefore has no expiration date.